Angola Commits USD 5 Million to Africa Centres for Disease Control and Prevention (CDC), Championing Africa-Led Health Financing Strategy
The announcement came after a high-level meeting held earlier that week, on April 21, in Luanda between President Lourenço and Dr. Jean Kaseya, Director General of Africa CDC. During the meeting, the two leaders discussed regional health priorities and the urgent need to mitigate the impact of declining development assistance.
Reacting to the pledge, Dr. Kaseya commended President Lourenço's bold and visionary leadership: 'President Lourenço's leadership reflects Africa's collective determination to finance our health future,' said Dr. Kaseya. 'This commitment is not only historic—it sends a powerful signal that Africa is ready to lead from the front, with bold investments and African-led solutions.'
President Lourenço also committed to convening a Committee of African Heads of State to champion the implementation of Africa CDC's continental strategy, 'Rethinking African Health Financing in a New Era' — a bold response to the sharp 70% decline in external development assistance for health across the continent.
In support of local manufacturing, Dr. Kaseya announced that Africa CDC will support Angola's plan for production of mosquito bed nets —an initiative aimed at strengthening vector control and expanding regional production capacity. President Lourenço welcomed Africa CDC's commitment to advancing local manufacturing of health commodities and confirmed that a major national initiative aligned with this vision will soon be launched.
The two leaders also discussed Angola's response to the ongoing cholera outbreak, with Dr. Kaseya commending the country's efforts and reaffirming Africa CDC's full financial and technical support. He further acknowledged Angola's essential role in advancing continental solidarity and public health resilience.
This announcement marks a major milestone in Africa CDC's continued efforts to rally political leadership, domestic financing, and unified continental action around the New Public Health Order and the Lusaka Agenda. The agency continues to work closely with all AU Member States to build inclusive, self-reliant, and resilient health systems for Africa's 1.4 billion people.
Distributed by APO Group on behalf of Africa Centres for Disease Control and Prevention (Africa CDC).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Middle East Eye
04-08-2025
- Middle East Eye
UK to announce plan to bring Palestinian children for NHS care 'within weeks'
The UK government will reportedly announce a plan to bring up to 300 acutely ill Palestinian children from Gaza for free medical treatment in the NHS "within weeks". Each child brought to the UK will be accompanied by a parent or guardian and siblings if neccessary with some expected never to return home, according to The Sunday Times which was briefed by a senior Whitehall source. The policy shift follows a 20-month campaign by doctors, lawyers and humanitarians who have called on the government to establish a scheme for Palestinian children similar to one created for Ukrainians. Israel's assault on Gaza that followed the Hamas-led 7 October attacks have destroyed Gaza's healthcare system. At least 12,000 adults and children are in need of medical evacuations, according to the World Health Organisation. Since October 2023, over 7,000 Palestinians have been evacuated, mostly to Egypt, the UAE and Qatar, with Jordan, European countries - particularly Italy, Spain and Romania - and the US taking much of the rest. The UK has allowed three Palestinian children into the country for privately funded medical treatment, including Majd al-Shagnobi, 15, who arrived last week. New MEE newsletter: Jerusalem Dispatch Sign up to get the latest insights and analysis on Israel-Palestine, alongside Turkey Unpacked and other MEE newsletters All three were brought by the UK-based group Project Pure Hope. In February, Shagnobi was reportedly trying to collect humanitarian aid in northern Gaza when an Israeli tank shell exploded, destroying his jaw and leaving him with significant injuries to his face. Former Gaza contractor says Israeli soldiers were ready to shoot starving children Read More » He is expected to undergo complex facial reconstructive surgery at Great Ormond Street Hospital. A spokesperson for Project Pure Hope, which has been one of the groups pushing the UK to establish a scheme, said it was "thrilled" to contribute government's task force and share its expertise from previous successful evacautions. "Our blueprint can halpe ensure that the UK acts quickly and effectively, so that every child who needs urgent care has the best chance of survival and recovery," the spokesperson said.
Zawya
31-07-2025
- Zawya
Africa Centres for Disease Control and Prevention (Africa CDC) and European Commission Launch New Initiative to Strengthen Mpox Testing and Sequencing Across Africa
The Africa Centres for Disease Control and Prevention (Africa CDC) and the European Commission today announced the launch of the Partnership to Accelerate Mpox Testing and Sequencing in Africa (PAMTA), a landmark initiative to boost diagnostics and outbreak response capabilities in Mpox-affected African countries. Co-funded under the EU4Health 2024 Work Programme, PAMTA reflects the growing momentum of Africa–EU health cooperation and aims to reinforce the continent's resilience against current and future health threats. The initiative will accelerate testing, sequencing, capacity building, and local manufacturing efforts for mpox and other priority pathogens across Africa through a €9.4 million to Africa CDC and the African Society for Laboratory Medicine (ASLM), managed by the European Health and Digital Executive Agency (HaDEA). The project officially began on 1 June 2025 and will be implemented over three years. Africa CDC Director General, H.E. Dr Jean Kaseya, welcomed the initiative as a timely and strategic intervention to close the diagnostic gap for Mpox and other outbreaks in Africa. 'This partnership reflects our commitment to working with trusted partners to build agile and self-reliant public health systems across Africa. Together with the EU and our technical partners, we are setting a new benchmark for outbreak detection and response.' The PAMTA initiative focuses on four key objectives: scaling up Mpox testing with the goal of supporting over 150,000 tests across the continent; strengthening genomic sequencing capacity to track viral evolution and spread; building human resource capacity in molecular diagnostics, genomics, bioinformatics and data interpretation; and promoting the production and validation of locally developed testing kits within Africa. 'PAMTA marks a historic milestone as the first initiative jointly signed between the European Commission and Africa CDC,' said Deputy Head of DG HERA, Laurent Muschel. 'Building on HERA's earlier donation of Mpox vaccines, this action enables a critical next step: strengthening diagnostic capacities as part of a broader medical countermeasures approach. It reflects our shared commitment to reinforcing epidemic preparedness across Africa — from vaccines to diagnostics, from innovation to manufacturing. This action shows that, together, the African Union and the European Union can deliver tangible results to protect lives.' The launch of PAMTA builds on broader efforts by the EU and its partners to address the Mpox outbreak. By mid-2025, more than 600,000 vaccine doses had been delivered to African countries through HERA and Team Europe. Simultaneously, research initiatives such as MPX-RESPONSE and EDCTP3 continue to explore new therapeutic options, while the Africa Pathogen Genomics Initiative (PGI)—also funded through EU4Health—is enhancing public health laboratory networks and genomic surveillance across the continent through public private partnerships. PAMTA marks a significant milestone in EU–Africa collaboration for health resilience. By supporting comprehensive diagnostics and fostering local innovation, the initiative is helping to lay a strong foundation for Africa's long-term pandemic preparedness and response capabilities. Distributed by APO Group on behalf of Africa Centres for Disease Control and Prevention (Africa CDC).
Zawya
30-07-2025
- Zawya
AI chatbots can boost public health in Africa
Language technologies like generative artificial intelligence (AI) hold significant potential for public health. From outbreak detection systems that scan global news in real time, to chatbots providing mental health support and conversational diagnostic tools improving access to primary care, these innovations are helping address health challenges. At the heart of these developments is natural language processing, an interdisciplinary field within AI research. It enables computers to interpret, understand and generate human language, bridging the gap between humans and machines. Natural language processing can process and analyse enormous volumes of health data, far more than humans could ever handle manually. This is especially valuable in regions with a stretched healthcare workforce or limited public health surveillance infrastructure, because it enables faster, data-driven responses to public health needs. Recently, our interdisciplinary team, combining expertise from computer science, human geography and health sciences, conducted a review of studies on how language AI is being used for public health in African countries. Almost a decade's worth of academic research was analysed, to understand how this powerful technology is being applied to pressing human needs. Out of 54 research publications, we found that evidence of real-world effects of the technology was still rare. Only 4% of these studies (two out of 54) showed measurable improvements in public health, such as boosting people's mood or increasing vaccine intentions. Most projects stop at technology development and publication. Very few advance to real-world use or impact. Opportunities to improve health and well-being across the continent could be missed as a result. Current limitations In recent years, AI language technologies for public health have increased rapidly. This wave of technology development really took off as the COVID-19 pandemic renewed attention to public health. Health chatbots and sentiment analysis tools were developed in Africa and beyond. Health chatbots 'talk' to people and provide reliable health information in a friendly, conversational way. Sentiment analysis tools scan social media posts to understand what people are feeling and talking about. Together they can identify misinformation or changes in public opinion and then provide accurate information. Of course, new technologies come with imperfections. We found that most technologies for public health in Africa exist in just a few languages whose dominance can be traced to colonial times, namely English and French. The consequences are clear: key health messages fail to reach many communities, leaving millions unable to access or act on essential information. We also found that few projects have gone beyond the laboratory development stage. Our study found only one system in operation that had a measurable public health effect. A successful model This standout example comes from a team at the Center for Global Development and the University of Chicago, in partnership with the Busara Center for Behavioral Economics. Their chatbot, deployed on Facebook Messenger, was designed for people in Kenya and Nigeria who were hesitant about COVID-19 vaccines. It was only available in English. More than 22,000 social media users used this app, sharing vaccine-related questions and concerns. The chatbot provided tailored, evidence-based responses to topics ranging from vaccine effectiveness and safety to misinformation. Its effect was notable. The intervention boosted users' intention and willingness to get vaccinated by 4%-5%. The strongest effects were seen among those most hesitant to begin with. Behind this success was the researchers' commitment to understanding the local context. Before launching the chatbot, in-depth discussions were held with focus groups and social media users in Kenya and Nigeria. The aim was to learn about the specific worries and cultural factors shaping attitudes toward vaccination. The chatbot was designed to address these concerns. This user-centred, locally adapted approach enabled the chatbot's messages to address real barriers. As this example demonstrates, language technologies for public health are most effective when responding to the concerns and needs of the intended users. From lab to life These technologies take time and money to be put into practice. The COVID-19 pandemic jump-started development but public health language AI technologies are very new. It could be that a future survey would find a very different situation. At the same time, advances in large language models such as GPT-4 are rapidly lowering the technical barriers to developing language technologies. These models can often be adapted to new applications with far less data and effort than previous methods. Recent advances could enable small teams of researchers or even individual developers to build tools tailored to the specific needs of their own communities. The path from lab to real-world effects may become much shorter and easier. Investors, accelerators and state support could help make this transition from lab to life happen. Technology developers can also contribute by rooting their work in community-driven, multi-disciplinary and cross-sector collaboration. Social science and public health research knowledge and skills can inform the design and development of new technologies. To maximise the potential of language technologies for public health, the following needs to happen: - involving communities and health workers in natural language processing design - expanding provision in indigenous African languages - integrating language technologies into existing health systems. Future research and development must move beyond technical prototypes and laboratory tests to rigorous real-world evaluations that measure health outcomes. The other co-authors behind this research are: Abigail Oppong, Ebele Mogo, Charlotte Collins, and Giulia Occhini.
